Cor Vasa 2025, 67(3):386-392 | DOI: 10.33678/cor.2025.038

(The use of cardiac magnetic resonance in the stratification of patients with dilated cardiomyopathy)

Tatiana Štípalováa, Roman Panovskýa, Mary Mojica-Pisciottib, Jan Krejčía
a I. interní kardioangiologická klinika, Lékařská fakulta Masarykovy univerzity a Fakultní nemocnice u sv. Anny v Brně a Mezinárodní centrum klinického výzkumu Fakultní nemocnice u sv. Anny v Brně, Brno, Česká republika
b Klinika zobrazovacích metod, Fakultní nemocnice u sv. Anny v Brně a Mezinárodní centrum klinického výzkumu Fakultní nemocnice u sv. Anny v Brně, Brno, Česká republika

Dilated cardiomyopathy (DCM) is one of the most common multifactorial cardiomyopathies that manifests mostly as heart failure with an increased risk of ventricular arrhythmias and/or sudden cardiac death.1 Detailed characterization of this process plays a key role in the prognostic stratification of DCM patients and in improving clinical therapy. applicability of standard and emerging CMR techniques.

Keywords: Cardiac magnetic resonance, Dilated cardiomyopathy, Parametric mapping,

Received: December 7, 2024; Revised: February 9, 2025; Accepted: March 10, 2025; Prepublished online: June 2, 2012; Published: June 20, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Štípalová T, Panovský R, Mojica-Pisciotti M, Krejčí J. (The use of cardiac magnetic resonance in the stratification of patients with dilated cardiomyopathy). Cor Vasa. 2025;67(3):386-392. doi: 10.33678/cor.2025.038.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    Attachments

    Download file386_392_Prehledovy_clanek_Stipalova.pdf

    File size: 3.5 MB

    References

    1. Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases. Eur Heart J 2007;29:270-276. Go to original source... Go to PubMed...
    2. Merlo M, Gagno G, Baritussio A, et al. Clinical application of CMR in cardiomyopathies: evolving concepts and techniques: A position paper of myocardial and pericardial diseases and cardiac magnetic resonance working groups of Italian society of cardiology. Heart Fail Rev 2023;28:77-95. Go to original source... Go to PubMed...
    3. Perone F, Dentamaro I, La Mura L, et al. Current Insights and Novel Cardiovascular Magnetic Resonance-Based Techniques in the Prognosis of Non-Ischemic Dilated Cardiomyopathy. J Clin Med 2024;13:1017. Go to original source... Go to PubMed...
    4. Mitropoulou P, Georgiopoulos G, Figliozzi S, et al. Multi-Modality Imaging in Dilated Cardiomyopathy: With a Focus on the Role of Cardiac Magnetic Resonance. Front Cardiovasc Med 2020;7:97. Go to original source... Go to PubMed...
    5. Gulati A, Ismail TF, Jabbour A, et al. The Prevalence and Prognostic Significance of Right Ventricular Systolic Dysfunction in Nonischemic Dilated Cardiomyopathy. Circulation 2013;128:1623-1633. Go to original source... Go to PubMed...
    6. Panovský R. Stručný přehled možností a limitací magnetické rezonance srdce. Interv Akut Kardiol 2021;20:233-237. Go to original source...
    7. Táborský M, Kautzner J, Linhart A, et al., eds. Kardiologie. Praha: Česká kardiologická společnost, 2021.
    8. Gigli M, Merlo M, Graw SL, et al. Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy. J Am Coll Cardiol 2019;74:1480-1490. Go to original source... Go to PubMed...
    9. Halliday BP, Gulati A, Ali A, et al. Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction. Circulation 2017;135:2106-2115. Go to original source... Go to PubMed...
    10. Chow K, Flewitt JA, Green JD, et al. Saturation recovery single--shot acquisition (SASHA) for myocardial T1 mapping. Magn Reson Med 2014;71:2082-2095. Go to original source... Go to PubMed...
    11. Higgins DM, Ridgway JP, Radjenovic A, et al. T1 measurement using a short acquisition period for quantitative cardiac applications. Med Phys 2005;32:1738-1746. Go to original source... Go to PubMed...
    12. Weingärtner S, Akçakaya M, Basha T, et al. Combined saturation/inversion recovery sequences for improved evaluation of scar and diffuse fibrosis in patients with arrhythmia or heart rate variability. Magn Reson Med 2014;71:1024-1034. Go to original source... Go to PubMed...
    13. Messroghli DR, Moon JC, Ferreira VM, et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson 2017;19:75. Erratum in: J Cardiovasc Magn Reson 2018;20:9. Go to original source... Go to PubMed...
    14. Haaf P, Garg P, Messroghli DR, et al. Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review. J Cardiovasc Magn Reson 2017;18:89. Go to original source... Go to PubMed...
    15. Sado DM, Flett AS, Banypersad SM, et al. Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. Heart 2012;98:1436-1441. Go to original source... Go to PubMed...
    16. Ugander M, Oki AJ, Hsu L-Y, et al. Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. Eur Heart J 2012;33:1268-1278. Go to original source... Go to PubMed...
    17. Cadour F, Quemeneur M, Biere L, et al. Prognostic Value of Cardiovascular Magnetic Resonance T1 Mapping and Extracellular Volume Fraction in Nonischemic Dilated Cardiomyopathy. J Cardiovasc Magn Reson 2023;25:7. Go to original source... Go to PubMed...
    18. Li S, Zhou D, Sirajuddin A, et al. T1 Mapping and Extracellular Volume Fraction in Dilated Cardiomyopathy: A Prognosis Study. JACC Cardiovasc Imaging 2022;15:578-590. Go to original source... Go to PubMed...
    19. Puntmann VO, Carr-White G, Jabbour A, et al. T1-Mapping and Outcome in Nonischemic Cardiomyopathy: All-Cause Mortality and Heart Failure. JACC Cardiovasc Imaging 2016;9:40-50. Go to original source... Go to PubMed...
    20. Kiaos A, Antonakaki D, Bazmpani MA, et al. Prognostic Value of Cardiovascular Magnetic Resonance T1 Mapping Techniques in Non-Ischemic Dilated Cardiomyopathy: A Systematic Review and Meta-Analysis. Int J Cardiol 2020;312:110-116. Go to original source... Go to PubMed...
    21. Mordi I, Carrick D, Bezerra H, Tzemos N. T1 and T2 mapping for early diagnosis of dilated non-ischaemic cardiomyopathy in middle-aged patients and differentiation from normal physiological adaptation. Eur Heart J Cardiovasc Imaging 2016;17:797-803. Go to original source... Go to PubMed...
    22. Kirk P, Roughton M, Porter JB, et al. Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation 2009;120:1961-1968. Go to original source... Go to PubMed...
    23. Rajiah PS, Kalisz K, Broncano J, et al. Myocardial Strain Evaluation with Cardiovascular MRI: Physics, Principles, and Clinical Applications. Radiographics 2022;42:968-990. Go to original source... Go to PubMed...
    24. Eichstaedt HW, Felix R, Danne O, et al. Imaging of Acute Myocardial Infarction by Magnetic Resonance Tomography (MRT) Using the Paramagnetic Relaxation Substance Gadolinium-DTPA. Cardiovasc Drugs Ther 1989;3:779-788. Go to original source... Go to PubMed...
    25. Byrne RA, Rossello X, Coughlan JJ, et al. ESC Scientific Document Group, 2023 ESC Guidelines for the management of acute coronary syndromes: Developed by the Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology (ESC). Eur Heart J 2023;44:3720-3826. Go to original source... Go to PubMed...
    26. Panovsky R, Borova J, Pleva M, et al. The unique value of cardiovascular magnetic resonance in patients with suspected acute coronary syndrome and culprit-free coronary angiograms. BMC Cardiovasc Disord 2017;17:170. Go to original source... Go to PubMed...
    27. Poloczková H, Honek T, Chaloupka A, et al. News in diagnostics and treament of cardiomyopathies. Vnitr Lek 2023;69:89-104. Go to original source... Go to PubMed...
    28. Ferreira VM, Schulz-Menger J, Holmvang G, et al. Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations. J Am Coll Cardiol 2018;72:3158-3176. Go to original source... Go to PubMed...
    29. Bohnen S, Radunski UK, Lund GK, et al. Performance of t1 and t2 mapping cardiovascular magnetic resonance to detect active myocarditis in patients with recent-onset heart failure. Circ Cardiovasc Imaging 2015;8:e003073. Go to original source... Go to PubMed...
    30. Spieker M, Haberkorn S, Gastl M, et al. Abnormal T2 mapping cardiovascular magnetic resonance correlates with adverse clinical outcome in patients with suspected acute myocarditis. J Cardiovasc Magn Reson 2017;19:38. Go to original source... Go to PubMed...
    31. Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. 2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 2022;43:3997-4126. Go to original source... Go to PubMed...
    32. Rubiś PP, Dziewięcka EM, Banyś P, al. Extracellular volume is an independent predictor of arrhythmic burden in dilated cardiomyopathy. Sci Rep 2021;11:24000. Go to original source... Go to PubMed...
    33. Di Marco A, Brown PF, Bradley J, et al. Extracellular volume fraction improves risk-stratification for ventricular arrhythmias and sudden death in non-ischaemic cardiomyopathy. Eur Heart J Cardiovasc Imaging 2023;24:512-521. Go to original source... Go to PubMed...
    34. Romano S, Judd RM, Kim RJ, et al. Feature-tracking global longitudinal strain predicts death in a multicenter population of patients with ischemic and nonischemic dilated cardiomyopathy incremental to ejection fraction and late gadolinium enhancement. JACC Cardiovasc Imaging 2018;11:1419-1429. Go to original source... Go to PubMed...
    35. Buss SJ, Breuninger K, Lehrke S, et al. Assessment of myocardial deformation with cardiac magnetic resonance strain imaging improves risk stratification in patients with dilated cardiomyopathy. Eur Heart J Cardiovasc Imaging 2015;16:307-315. Go to original source... Go to PubMed...
    36. Romano S, Mansour IN, Kansal M, et al. Left ventricular global longitudinal strain predicts heart failure readmission in acute decompensated heart failure. Cardiovasc Ultrasound 2017;15:6. Go to original source... Go to PubMed...
    37. Ochs A, Riffel J, Ochs MM, et al. Myocardial mechanics in dilated cardiomyopathy: prognostic value of left ventricular torsion and strain. J Cardiovasc Magn Reson 2021;23:136. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes